Clinical and Educational Summary

Dr. Gerald Tramontano specializes in the practice of clinical neuropsychology. He is the Director of the Center for Cognitive and Memory Disorders from Neurodegenerative Diseases and of the Sleep Study and Treatment Center at the NeuroCognitive & Behavioral Institute (NCBI). He provides direct patient care for patients at these centers which includes interpretation of neurodiagnostics studies, developing neuromodulation enhanced therapy and rehabilitation treatment plans as well as ongoing evaluation, management, and treatments for these patients at these centers. He also assists in providing interpretation and feedback to patients and their families receiving care at the Neurodevelopmental, Acquired and Traumatic Brain Injury and Neuropsychiatric centers at NCBI. NCBI serves patients with a variety of cognitive and neuropsychiatric conditions ranging from ADHD through Alzheimer’s disease.

Dr. Tramontano completed his undergraduate studies at Boston University with a major in psychology and a minor in biology graduating summa cum laude. He completed his doctoral degree in clinical psychology at St. John’s University in NYC graduating magna cum laude. His clinical psychology and clinical neuropsychology internship were completed at Tufts University School of Medicine and the Boston VA Medical Center Consortium. His fellowship training was completed at Brown University School of Medicine in clinical neuropsychology. His neuromodulation clinical fellowship training was completed at Harvard Medical School Sidney Baer, at the Boston Beth Israel Deaconess Medical Center at the Berenson Allen Center for Non-invasive Brain Stimulation, and his fMRI fellowship at Harvard Medical School’s Athinoula A. Martinos Center for Bioimaging. He is also completing his masters and clinical psychopharmacology training at Farleigh Dickinson University.

Clinical Research Summary

Dr. Tramontano conducts a variety of sponsored and investigator-initiated pharmacological, nutraceutical, medical device and neurodiagnostic clinical research. As a Principal Investigator, Dr. Tramontano has completed approximately 75 clinical research studies. His clinical research experience in drug development ranges from bioavailability/bioequivalent studies as well as first in human Phase I studies through Phase IV clinical trials. Most of his investigated initiated clinical research has been investigating functional brain mapping, neuromodulation, behavioral, biological, and pharmacological treatments for patients with a variety of cognitive and neuropsychiatric conditions, in particular – neurodegenerative diseases such as Alzheimer’s disease. He has authored several published neuroscience-related and pharmacology articles in neuroscience and forensic journals. 

As a Principal Investigator Dr. Tramontano has completed approximately 70 clinical research studies.  His clinical research experience in drug development ranges from bioavailability / bioequivalent studies as well as first in humans Phase I studies through Phase IV clinical trials.  Most of his clinical research has been investigating functional brain mapping, neuromodulation, behavioral, biological, and pharmacological treatments for patients with a variety of cognitive and neuropsychiatric conditions, in particular – neurodegenerative diseases such as Alzheimer’s disease.  He has authored several published neuroscience-related articles in medical journals.

Academic Affiliations and Professional Activities

Dr. Tramontano is a Clinical Assistant Professor of Psychiatry at Rutgers Medical School – formerly UMDNJ-Robert Wood Johnson Medical School and was a faculty member of the Cerebral Dysfunction Clinic at the medical school. He is an Assistant Professor in Psychology at St. John’s University teaching
clinical neuropsychology in the Ph.D. Clinical Psychology Program. He has authored and published neuroscience-related and psychopharmacology articles in peer reviewed medical and medicolegal journals. (https://independent.academia.edu/GeraldTramontano)

He has successfully testified as a medicolegal expert in federal, state, criminal, and civil cases. Dr. Tramontano is an active and long-standing member of the American Academy of Neurology, the American Neuropsychiatric Association, the National Academy of Neuropsychologists, American Psychological Association and the Association for Applied Psychophysiology and Biofeedback.
He supervises the clinical staff at NCBI. In the past he has been a clinical supervisor for medical and psychology interns, residents and fellows in clinical neuropsychology, behavioral neurology, and psychiatry.